HeartSciences Inc.
HSCS · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Market Cap | $8,481 | $4,067 | $3,909 | $3,185 |
| - Cash | $1,951,103 | $2,792 | $1,098 | $2,597 |
| + Debt | $876,240 | $1,947 | $2,985 | $2,987 |
| Enterprise Value | -$1,066,382 | $3,222 | $5,796 | $3,576 |
| Revenue | $2 | $2 | $4 | $0 |
| % Growth | 27.3% | -56.3% | – | – |
| Gross Profit | -$31 | $1 | -$29 | $0 |
| % Margin | -1,282.5% | 60% | -661.9% | – |
| EBITDA | -$2,039 | -$1,840 | -$1,882 | -$2,328 |
| % Margin | -84,282.8% | -96,822.7% | -43,269.4% | – |
| Net Income | -$2,351 | -$2,055 | -$2,094 | -$2,536 |
| % Margin | -97,179.4% | -108,157.6% | -48,145.5% | – |
| EPS Diluted | -0.85 | -1.58 | -1.88 | -2.57 |
| % Growth | 46.2% | 16% | 26.8% | – |
| Operating Cash Flow | -$2,334,266 | -$1,953 | -$1,591 | -$1,620 |
| Capital Expenditures | -$13,030 | -$1 | -$8 | -$16 |
| Free Cash Flow | -$2,347,296 | -$1,954 | -$1,598 | -$1,636 |